A Single Center, Randomized, Double Blinded PhaseI/IIa Exploratory Study to Evaluate Reactogenicity, Safety, Immunogenicity and Dose Response of a New Hepatitis B Vaccine in Human Adult
Latest Information Update: 22 Nov 2023
At a glance
- Drugs CVI HBV 001 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Cha Vaccine Institute
- 07 Mar 2016 New trial record